Volume s1-26, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



In a series of 25 cases of bubonic plague, 16 patients were treated with sulfadiazine alone, 3 with sulfadiazine plus antiplague serum, 4 with sulfathiazole and serum at first but later with sulfadiazine and 2 with sulfathiazole alone. There were five fatalities—3 deaths among patients treated with sulfadiazine and 2 deaths among those treated with sulfadiazine plus serum. While admittedly a small series, the results are sufficiently striking to show the excellent therapeutic value of sulfadiazine in the treatment of bubonic plague. Some interesting findings concerning the importance of early treatment, persistence of plague bacilli in the bubo, occurrence of relapses and instances of prompt response to sulfadiazine after failure with sulfathiazole are presented and discussed.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error